XB-FEAT-480845: Difference between revisions
Jump to navigation
Jump to search
imported>Xenbase |
imported>Xenbase |
||
| Line 4: | Line 4: | ||
=nomenclature changes= | =nomenclature changes= | ||
12/18/2017 | 12/18/2017 | ||
Human name has changed for Entrez Gene: 607. From B-cell CLL/lymphoma 9 to B cell CLL/lymphoma 9 | Human name has changed for Entrez Gene: 607. From B-cell CLL/lymphoma 9 to B cell CLL/lymphoma 9. | ||
03.04.2019 | |||
Human name has changed for Entrez Gene: 607. From B cell CLL/lymphoma 9 to BCL9 transcription coactivator | |||
=NCBI Summary= | =NCBI Summary= | ||
BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. [provided by RefSeq, Jul 2008] | BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. [provided by RefSeq, Jul 2008] | ||
Latest revision as of 10:58, 3 April 2019
bcl9
This is the community wiki page for the gene bcl9 please feel free to add any information that is relevant to this gene that is not already captured elsewhere in Xenbase
nomenclature changes
12/18/2017 Human name has changed for Entrez Gene: 607. From B-cell CLL/lymphoma 9 to B cell CLL/lymphoma 9.
03.04.2019 Human name has changed for Entrez Gene: 607. From B cell CLL/lymphoma 9 to BCL9 transcription coactivator
NCBI Summary
BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. [provided by RefSeq, Jul 2008]